How much funding has SuperGen raised?

SuperGen has raised $391.6M in total funding, most recently a Corporate Round.

Who are SuperGen's investors?

SuperGen's investors include GlaxoSmithKline.

Where is SuperGen headquartered?

SuperGen is headquartered in Dublin, California, United States.

How many employees does SuperGen have?

SuperGen has 201-500 employees.

SuperGen

Closed

Dedicated to the development of novel cancer therapies.

Public · Dublin, United States · Founded 1991 · $391.6M raised

Biotech

Headquarters: Dublin, California
Employees: 201–500
Founded: 1991
Business Model: B2B
Website: supergen.com

Total Funding: $391.6M
Last Round: $375.0M Corporate RoundOct 2009
Rounds: 2
Type: Public

About

SuperGen, Inc. was a Dublin, California-based pharmaceutical company dedicated to the discovery, acquisition, rapid development, and commercialization of cancer therapeutics. Founded in 1991 and listed on Nasdaq (SUPG), the company built a portfolio of oncology drugs including Dacogen (decitabine). In 2011, SuperGen merged with Astex Therapeutics to form Astex Pharmaceuticals, Inc., which was subsequently acquired by Otsuka Pharmaceutical.

Summary

SuperGen is a Biotech company based in Dublin, United States, founded in 1991. It has raised $391.6M in total across 2 rounds, most recently a $375.0M Corporate Round round in Oct 2009. Investors include GlaxoSmithKline.